Concepedia

Dexrazoxane prevents doxorubicin‐induced long‐term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats

Dirk Lebrecht, Andrea Geist, U‐P Ketelsen, Jörg Haberstroh, B. Setzer, Ulrich A. Walker

British Journal of Pharmacology · 2007 · 136 citations · 36 references

DOIFull text

Open access

Abstract

Dexrazoxane prevented doxorubicin induced late-onset cardiomyopathy and also protected the cardiac mitochondria from acquired ultrastructural, genetic and functional damage.

References

36

Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II

K M Tewey, Thomas C. Rowe, Liu Yang et al. · Science · 1984 · 1.5K citations

, , +16

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Sandra M. Swain, Fredrick S. Whaley, Mirjam C. Gerber et al. · Journal of Clinical Oncology · 1997 · 647 citations

Superoxide Production in Vascular Smooth Muscle Contributes to Oxidative Stress and Impaired Relaxation in Atherosclerosis

Francis J. Miller, David D. Gutterman, Cristina Rios et al. · Circulation Research · 1998 · 621 citations · Full text

A Direct Repeat Is a Hotspot for Large-Scale Deletion of Human Mitochondrial DNA

Eric A. Schon, Rosario Rizzuto, Carlos T. Moraes et al. · Science · 1989 · 579 citations

, , +23

Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.

April C. Childs, Sharon Phaneuf, Amie J. Dirks et al. · PubMed · 2002 · 452 citations

, , +17